Related Experiment Video
Updated: Sep 14, 2025

13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
14.2K
Implementation of Neonatal Screening Program for Congenital Hypothyroidism in Eastern Morocco
Fatima Wahoud1, Samia Essadki2, Khadija Zirar1
1Maternal Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University, Oujda 60049, Morocco.
International Journal of Neonatal Screening
|July 23, 2025
Summary
Newborn screening in eastern Morocco identified a congenital hypothyroidism (CH) birth prevalence of 1:1354. Delays in sample collection and TSH result turnaround times impact timely diagnosis and intervention for this preventable cause of intellectual disability.
Area of Science:
- Endocrinology
- Public Health
- Neonatal Medicine
Background:
- Congenital hypothyroidism (CH) is a leading preventable cause of intellectual disability worldwide.
- Early detection through newborn screening (NBS) is crucial for timely intervention and improved outcomes.
- Limited data exists on CH incidence and NBS program effectiveness in eastern Morocco.
Purpose of the Study:
- To evaluate the incidence of CH in eastern Morocco using a newborn screening program.
- To assess the effectiveness of the NBS program in detecting CH cases.
- To identify potential delays in the screening and diagnostic process.
Main Methods:
- A descriptive cross-sectional study involving 4062 newborns in eastern Morocco.
- Heel prick blood samples collected on blotting paper for Thyroid-Stimulating Hormone (TSH) measurement via immunofluorimetric assay.
- Analysis of TSH levels, recall rates, confirmatory testing results, and preanalytical/turnaround times.
Main Results:
- The birth prevalence of CH confirmed at birth was 1:1354 live births.
- TSH levels varied significantly by neonatal age at sampling (p < 0.001).
- A recall rate of 0.44% was observed, with 3 confirmed CH cases and 4 cases of transient hyperthyrotropinemia.
Conclusions:
- The NBS program in eastern Morocco is relevant for detecting CH, a preventable cause of intellectual disability.
- Significant delays in preanalytical steps (median 6 days) and TSH result turnaround (median 8 days) were noted.
- Addressing these delays is essential to enhance early diagnosis and management of CH in the region.

